Merit Medical Systems Inc (MMSI)
79.51
+0.54
(+0.68%)
USD |
NASDAQ |
May 06, 16:00
79.45
-0.06
(-0.08%)
After-Hours: 20:00
Merit Medical Systems Research and Development Expense (Quarterly): 21.48M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 21.48M |
| December 31, 2023 | 21.64M |
| September 30, 2023 | 19.65M |
| June 30, 2023 | 21.68M |
| March 31, 2023 | 21.31M |
| December 31, 2022 | 20.44M |
| September 30, 2022 | 19.22M |
| June 30, 2022 | 25.14M |
| March 31, 2022 | 17.39M |
| December 31, 2021 | 20.41M |
| September 30, 2021 | 16.97M |
| June 30, 2021 | 17.59M |
| March 31, 2021 | 16.27M |
| December 31, 2020 | 15.38M |
| September 30, 2020 | 13.51M |
| June 30, 2020 | 14.03M |
| March 31, 2020 | 14.87M |
| December 31, 2019 | 16.25M |
| September 30, 2019 | 16.99M |
| June 30, 2019 | 16.83M |
| March 31, 2019 | 16.07M |
| December 31, 2018 | 15.63M |
| September 30, 2018 | 14.60M |
| June 30, 2018 | 15.62M |
| March 31, 2018 | 14.32M |
| Date | Value |
|---|---|
| December 31, 2017 | 12.73M |
| September 30, 2017 | 24.90M |
| June 30, 2017 | 13.39M |
| March 31, 2017 | 12.52M |
| December 31, 2016 | 11.85M |
| September 30, 2016 | 11.72M |
| June 30, 2016 | 11.53M |
| March 31, 2016 | 10.59M |
| December 31, 2015 | 11.42M |
| September 30, 2015 | 11.52M |
| June 30, 2015 | 9.202M |
| March 31, 2015 | 9.672M |
| December 31, 2014 | 9.523M |
| September 30, 2014 | 8.688M |
| June 30, 2014 | 9.641M |
| March 31, 2014 | 8.78M |
| December 31, 2013 | 8.822M |
| September 30, 2013 | 7.308M |
| June 30, 2013 | 8.648M |
| March 31, 2013 | 9.108M |
| December 31, 2012 | 7.665M |
| September 30, 2012 | 7.373M |
| June 30, 2012 | 8.591M |
| March 31, 2012 | 6.616M |
| December 31, 2011 | 11.93M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
13.51M
Minimum
Sep 2020
25.14M
Maximum
Jun 2022
18.35M
Average
17.49M
Median
Research and Development Expense (Quarterly) Benchmarks
| Becton Dickinson & Co | 299.00M |
| Integer Holdings Corp | 15.75M |
| Abbott Laboratories | 684.00M |
| Boston Scientific Corp | 366.00M |
| Insulet Corp | 42.00M |